New rule on foreign drug importation is likely to result in additional costs, undercutting cost-saving goal

New complexities will cost money to implement, which could hinder potential savings and hurt innovation.

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive